The American Chemical Society has awarded Kevin Schug with the J. Calvin Giddings Award for Excellence in Education in recognition of his efforts to improve the educational experience of students in the field of analytical chemistry.
The American Chemical Society has awarded Kevin Schug with the J. Calvin Giddings Award for Excellence in Education in recognition of his efforts to improve the educational experience of students in the field of analytical chemistry.
Speaking about the award Schug said, “Given the past recipients of this award, this is a tremendous honour. Teaching at University of Texas Arlington (UTA) has been a really fulfilling part of my job, and it is really humbling to be honoured like this for that effort.”
Schug, who also directs UTA’s Collaborative Laboratories for Environmental Analysis and Remediation or CLEAR Lab, becomes the second member of UTA’s Department of Chemistry and Biochemistry to win the Giddings Award in three years; Purnendu “Sandy” Dasgupta, the Hamish Small Chair in Ion Analysis and Jenkins Garrett Professor of Chemistry and Biochemistry, also received the honour in 2015.
“Dr. Schug is passionate about teaching and about improving science education,” said Morteza Khaledi, College of Science Dean. “He has received numerous awards and commendations for his teaching and mentoring efforts, and the ACS J. Calvin Giddings Award is a well-deserved affirmation of his extraordinary efforts on behalf of students to make sure they receive the best possible educational experience.”
Since joining the UTA Department of Chemistry and Biochemistry, Schug’s research has been focused on the theory and application of separation science, mass spectrometry, and spectroscopy for solving a variety of analytical problems spanning the energy, environmental, biological, and pharmaceutical fields. He was also instrumental in building the relationship between UTA and Shimadzu Scientific Instruments, Inc., which in 2013 led to the creation of the Shimadzu Institute for Research Technologies, comprised of multiple instrumentation facilities, each with a different research focus, and operated under the “centralized research resources” model.
To read Kevin’s LCGC blog please click here: www.chromatographyonline.com/lcgc-blog
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.